Commonwealth Equity Services
OVID icon

Commonwealth Equity Services’s Ovid Therapeutics OVID Stock Holding History

Commonwealth Equity Services’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,400
Closed -$105K – 3246
2020
Q3 		$105K Buy
18,400
+1,000
+6% +$6.69K ﹤0.01% 2873
2020
Q2 		$128K Hold
17,400
– – ﹤0.01% 2728
2020
Q1 		$51K Sell
17,400
-500
-3% -$1.69K ﹤0.01% 2680
2019
Q4 		$74K Buy
17,900
+500
+3% +$1.58K ﹤0.01% 2770
2019
Q3 		$56K Buy
+17,400
New +$39.5K ﹤0.01% 2733

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Commonwealth Equity Services's OVID Position: Q4 2020 in Review

Commonwealth Equity Services sold out of Ovid Therapeutics (OVID) in Q4 2020, closing a stake of 18,400 shares — an estimated $105K sold.

Commonwealth Equity Services first reported a position in OVID in Q3 2019 and held it in 5 quarters. The position peaked at $128K in Q2 2020. 83 funds tracked by Wall St. Rank hold OVID as of Q4 2020.

  • Commonwealth Equity Services reported no remaining Ovid Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Commonwealth Equity Services sold 18,400 Ovid Therapeutics shares in Q4 2020, an estimated $105K.
  • Commonwealth Equity Services first reported a position in Ovid Therapeutics in Q3 2019 and held it in 5 quarters.
  • Commonwealth Equity Services's Ovid Therapeutics position peaked at $128K in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2020.

Based on Commonwealth Equity Services's 13F filing for Q4 2020, filed 11 Feb 2021.